CD8A and neoplasm: What is more, immunity-related pathways including MHC class-II, MHC class-I, immune checkpoint, CD8 T effector, ICB resistance, and tumor-associated pathways containing cell cycle, EMT, and ferroptosis were all positively enriched in the high-risk group.